Fatores prognósticos do derrame pleural neoplásico
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório do Centro Universitário Braz Cubas |
Texto Completo: | https://repositorio.cruzeirodosul.edu.br/handle/123456789/1437 |
Resumo: | Introduction: Cancer is the second most common cause of death in the world and in Brazil, followed only by cardiovascular diseases. Neoplastic pleural effusion is currently the second leading cause of exudative pleural effusions and usually occurs due to metastatic disease or primary malignant disease located in the pleura and which indicates incurability of the underlying disease. The earliest symptoms presented by patients include pleuritic pain and dyspnoea. Treatment should aim to relieve dyspnea in a minimally invasive manner and with the shortest possible hospital stay. The prognostic factors that determine survival in this pathology are of great relevance, since they can guide the appropriate management according to the vital capacity of these patients, enabling a better approach, aiming at an increase in the quality of life. Objective: Describe which factors determine prognosis in patients with neoplastic pleural effusion. Describe prognostic factors that affect survival and quality of life in these patients. Methods: Integrative, exploratory and descriptive bibliographic research, carried out on secondary sources of the topic under study. Data collection was carried out during the months of October and November 2020. Articles from the last 10 years (2010 - 2020), in English and Portuguese, were included. Results and Discussion: Survival was related to prognostic factors including the type of the primary tumor, the ECOG performance score, the neutrophil-lymphocyte ratio and the levels of lactic dehydrogenase in the pleural fluid. Leukocytosis, hypoalbuminemia and hypoxemia have been associated with a significant reduction in postoperative survival in patients with malignant effusion. Final considerations: The knowledge of prognostic factors is of great relevance, since they are guides for the proper management of each patient, always with the objective of reducing hospital stay and complete resolution of symptoms in these patients. |
id |
CUB_0eb4aa970735b497934685beaee407f6 |
---|---|
oai_identifier_str |
oai:repositorio.cruzeirodosul.edu.br:123456789/1437 |
network_acronym_str |
CUB |
network_name_str |
Repositório do Centro Universitário Braz Cubas |
repository_id_str |
|
spelling |
Fatores prognósticos do derrame pleural neoplásicoDerrame pleural malignoDoenças pleuraisPrognósticoCNPQ::CIENCIAS DA SAUDE::MEDICINAIntroduction: Cancer is the second most common cause of death in the world and in Brazil, followed only by cardiovascular diseases. Neoplastic pleural effusion is currently the second leading cause of exudative pleural effusions and usually occurs due to metastatic disease or primary malignant disease located in the pleura and which indicates incurability of the underlying disease. The earliest symptoms presented by patients include pleuritic pain and dyspnoea. Treatment should aim to relieve dyspnea in a minimally invasive manner and with the shortest possible hospital stay. The prognostic factors that determine survival in this pathology are of great relevance, since they can guide the appropriate management according to the vital capacity of these patients, enabling a better approach, aiming at an increase in the quality of life. Objective: Describe which factors determine prognosis in patients with neoplastic pleural effusion. Describe prognostic factors that affect survival and quality of life in these patients. Methods: Integrative, exploratory and descriptive bibliographic research, carried out on secondary sources of the topic under study. Data collection was carried out during the months of October and November 2020. Articles from the last 10 years (2010 - 2020), in English and Portuguese, were included. Results and Discussion: Survival was related to prognostic factors including the type of the primary tumor, the ECOG performance score, the neutrophil-lymphocyte ratio and the levels of lactic dehydrogenase in the pleural fluid. Leukocytosis, hypoalbuminemia and hypoxemia have been associated with a significant reduction in postoperative survival in patients with malignant effusion. Final considerations: The knowledge of prognostic factors is of great relevance, since they are guides for the proper management of each patient, always with the objective of reducing hospital stay and complete resolution of symptoms in these patients.Introdução: O câncer é a segunda causa mais comum de morte no mundo e no Brasil, seguido apenas das doenças cardiovasculares. O derrame pleural neoplásico atualmente é a segunda causa de derrames pleurais exsudativos e ocorrem geralmente devido a doença metastática ou doença maligna primária localizada na pleura e que indica incurabilidade da doença base. Os sintomas mais precoces apresentados pelos pacientes incluem dor pleurítica e a dispneia. O tratamento deve ter como objetivo aliviar a dispneia de maneira minimamente invasiva e com menor tempo de internação hospitalar possível. Os fatores prognósticos que determinam sobrevida nessa patologia são de importante relevância, visto que podem direcionar o manejo adequado de acordo com a capacidade vital desses pacientes, possibilitando uma melhor abordagem, visando um incremento na qualidade de vida. Objetivo: Descrever quais fatores determina prognóstico em pacientes portadores de derrame pleural neoplásico. Descrever fatores prognósticos que afetam sobrevida e qualidade de vida nesses pacientes. Métodos: Pesquisa bibliográfica integrativa, exploratória e descritiva, realizada em fontes secundárias do tema em estudo. A coleta de dados foi realizada durante os meses de Outubro e Novembro de 2020. Foram incluídos artigos dos últimos 10 anos (2010 - 2020), nos idiomas inglês e português. Resultados e Discussão: A sobrevida foi relacionada com fatores prognósticos que incluem o tipo do tumor primário, o escore desempenho da ECOG, a relação neutrófilo-linfócito e os níveis de desidrogenase lática no líquido pleural. Leucocitose, hipoalbuminemia e hipoxemia foram associados a uma redução significativa na sobrevida pós-operatória de pacientes com derrame maligno. Considerações finais: O conhecimento dos fatores prognósticos é de importante relevância, visto que são guias para o manejo adequado de cada paciente, sempre com objetivo de reduzir a estadia hospitalar e resolução completa dos sintomas nesses pacientes.Centro Universitário de João PessoaBrasilUNIPÊLima , David Paes dehttp://lattes.cnpq.br/5453174144154509Melo , Lucas Villar de2021-02-02T16:38:44Z2021-02-032021-02-02T16:38:44Z2020-12-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisapplication/pdfhttps://repositorio.cruzeirodosul.edu.br/handle/123456789/1437porANEVLAVIS, Stavros et al. Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration, v. 87, n. 4, p. 311-316, 2014 Acesso em: 17 nov, 2020. ASCIAK, Rachelle; RAHMAN, Najib M. Malignant pleural effusion: from diagnostics to therapeutics. Clinics in chest medicine, v. 39, n. 1, p. 181-193, 2018. Acesso em: 09 nov, 2020. BIBBY, Anna C. et al. ERS/EACTS statement on the management of malignant pleural effusions. European journal of cardio-thoracic surgery, v. 55, n. 1, p. 116-132, 2019. Acesso em: 17 dez. 2019. BIELSA, Silvia et al. Prognostic significance of pleural fluid data in patients with malignant effusion. European journal of internal medicine, v. 19, n. 5, p. 334-339, 2008. Acesso em: 17 nov, 2020. CLIVE, Amelia O. et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax, v. 69, n. 12, p. 1098-1104, 2014. Acesso em: 17 dez. 2019. DE OLIVEIRA SANTOS, Marceli. Estimate 2018: Cancer Incidence in Brazil. Revista Brasileira de Cancerologia, v. 64, n. 1, p. 119-120, 2018. Acesso em: 09 de set. 2019. FELLER-KOPMAN, David J. et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. American journal of respiratory and critical care medicine, v. 198, n. 7, p. 839-849, 2018. Acesso em: 22 nov. 2019. FELLER-KOPMAN, David; LIGHT, Richard. Pleural disease. New England Journal of Medicine, v. 378, n. 8, p. 740-751, 2018. Acesso em: 22 nov. 2019. FITZGERALD, Deirdre B. et al. Surgical and non-surgical management of malignant pleural effusions. Expert review of respiratory medicine, v. 12, n. 1, p. 15-26, 2018. Acesso em: 09 set. 2019. HOOPER, Clare et al. Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax, v.65, p.4-17, 2010. Acesso em: 09 set. 2019. JEBA, Jenifer et al. Prognostic factors of malignant pleural effusion among palliative care outpatients: A retrospective study. Indian Journal of Palliative Care, v. 24, n. 2, p. 184, 2018. Acesso em: 17 nov, 2020. KOEGELENBERG, Coenraad FN et al. Contemporary best practice in the management of malignant pleural effusion. Therapeutic advances in respiratory disease, v. 12, p. 1753466618785098, 2018. Acesso em: 17 nov, 2020. MARTINS et al. Clínica Médica Volume 3: doenças hematológicas, oncologia, doenças renais. 2. ed. São Paulo: Manole, 2016. p. 1-761. Acesso em: 09 set. 2019. PEREIRA, Carlos Alberto de Castro; HOLANDA, Marcelo Alcantara. Medicina respiratória. 1. ed. São Paulo: Atheneu, 2013. p. 1-2108. Acesso em: 09 set. 2019. PILLING, John E. et al. Prognostic factors for survival after surgical palliation of malignant pleural effusion. Journal of Thoracic Oncology, v. 5, n. 10, p. 1544-1550, 2010. Acesso em: 17 nov, 2020. SKOK, Kristijan et al. Malignant pleural effusion and its current management: a review. Medicina, v. 55, n. 8, p. 490, 2019. Acesso em: 17 nov, 2020. WALKER, Steven; BIBBY, Anna C.; MASKELL, Nick A. Current best practice in the evaluation and management of malignant pleural effusions. Therapeutic advances in respiratory disease, v. 11, n. 2, p. 105-114, 2017. Acesso em: 17 nov, 2020. WORLD HEALTH ORGANIZATION. Noncommunicable diseases country profiles 2018. Disponível em: https://www.who.int/. Acesso em: 20 set. 2019. ZAMBONI, Mauro et al. Fatores prognósticos para a sobrevida dos pacientes com derrame pleural maligno. Pulmão RJ, Rio de Janeiro, v. 25, n. 1, p. 43-52, 2018. Acesso em: 09 set. 2019.info:eu-repo/semantics/openAccessreponame:Repositório do Centro Universitário Braz Cubasinstname:Centro Universitário Braz Cubas (CUB)instacron:CUB2021-02-02T16:43:05Zoai:repositorio.cruzeirodosul.edu.br:123456789/1437Repositório InstitucionalPUBhttps://repositorio.brazcubas.edu.br/oai/requestbibli@brazcubas.edu.bropendoar:2021-02-02T16:43:05Repositório do Centro Universitário Braz Cubas - Centro Universitário Braz Cubas (CUB)false |
dc.title.none.fl_str_mv |
Fatores prognósticos do derrame pleural neoplásico |
title |
Fatores prognósticos do derrame pleural neoplásico |
spellingShingle |
Fatores prognósticos do derrame pleural neoplásico Melo , Lucas Villar de Derrame pleural maligno Doenças pleurais Prognóstico CNPQ::CIENCIAS DA SAUDE::MEDICINA |
title_short |
Fatores prognósticos do derrame pleural neoplásico |
title_full |
Fatores prognósticos do derrame pleural neoplásico |
title_fullStr |
Fatores prognósticos do derrame pleural neoplásico |
title_full_unstemmed |
Fatores prognósticos do derrame pleural neoplásico |
title_sort |
Fatores prognósticos do derrame pleural neoplásico |
author |
Melo , Lucas Villar de |
author_facet |
Melo , Lucas Villar de |
author_role |
author |
dc.contributor.none.fl_str_mv |
Lima , David Paes de http://lattes.cnpq.br/5453174144154509 |
dc.contributor.author.fl_str_mv |
Melo , Lucas Villar de |
dc.subject.por.fl_str_mv |
Derrame pleural maligno Doenças pleurais Prognóstico CNPQ::CIENCIAS DA SAUDE::MEDICINA |
topic |
Derrame pleural maligno Doenças pleurais Prognóstico CNPQ::CIENCIAS DA SAUDE::MEDICINA |
description |
Introduction: Cancer is the second most common cause of death in the world and in Brazil, followed only by cardiovascular diseases. Neoplastic pleural effusion is currently the second leading cause of exudative pleural effusions and usually occurs due to metastatic disease or primary malignant disease located in the pleura and which indicates incurability of the underlying disease. The earliest symptoms presented by patients include pleuritic pain and dyspnoea. Treatment should aim to relieve dyspnea in a minimally invasive manner and with the shortest possible hospital stay. The prognostic factors that determine survival in this pathology are of great relevance, since they can guide the appropriate management according to the vital capacity of these patients, enabling a better approach, aiming at an increase in the quality of life. Objective: Describe which factors determine prognosis in patients with neoplastic pleural effusion. Describe prognostic factors that affect survival and quality of life in these patients. Methods: Integrative, exploratory and descriptive bibliographic research, carried out on secondary sources of the topic under study. Data collection was carried out during the months of October and November 2020. Articles from the last 10 years (2010 - 2020), in English and Portuguese, were included. Results and Discussion: Survival was related to prognostic factors including the type of the primary tumor, the ECOG performance score, the neutrophil-lymphocyte ratio and the levels of lactic dehydrogenase in the pleural fluid. Leukocytosis, hypoalbuminemia and hypoxemia have been associated with a significant reduction in postoperative survival in patients with malignant effusion. Final considerations: The knowledge of prognostic factors is of great relevance, since they are guides for the proper management of each patient, always with the objective of reducing hospital stay and complete resolution of symptoms in these patients. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-21 2021-02-02T16:38:44Z 2021-02-03 2021-02-02T16:38:44Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://repositorio.cruzeirodosul.edu.br/handle/123456789/1437 |
url |
https://repositorio.cruzeirodosul.edu.br/handle/123456789/1437 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
ANEVLAVIS, Stavros et al. Prognostic factors in patients presenting with pleural effusion revealing malignancy. Respiration, v. 87, n. 4, p. 311-316, 2014 Acesso em: 17 nov, 2020. ASCIAK, Rachelle; RAHMAN, Najib M. Malignant pleural effusion: from diagnostics to therapeutics. Clinics in chest medicine, v. 39, n. 1, p. 181-193, 2018. Acesso em: 09 nov, 2020. BIBBY, Anna C. et al. ERS/EACTS statement on the management of malignant pleural effusions. European journal of cardio-thoracic surgery, v. 55, n. 1, p. 116-132, 2019. Acesso em: 17 dez. 2019. BIELSA, Silvia et al. Prognostic significance of pleural fluid data in patients with malignant effusion. European journal of internal medicine, v. 19, n. 5, p. 334-339, 2008. Acesso em: 17 nov, 2020. CLIVE, Amelia O. et al. Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score. Thorax, v. 69, n. 12, p. 1098-1104, 2014. Acesso em: 17 dez. 2019. DE OLIVEIRA SANTOS, Marceli. Estimate 2018: Cancer Incidence in Brazil. Revista Brasileira de Cancerologia, v. 64, n. 1, p. 119-120, 2018. Acesso em: 09 de set. 2019. FELLER-KOPMAN, David J. et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. American journal of respiratory and critical care medicine, v. 198, n. 7, p. 839-849, 2018. Acesso em: 22 nov. 2019. FELLER-KOPMAN, David; LIGHT, Richard. Pleural disease. New England Journal of Medicine, v. 378, n. 8, p. 740-751, 2018. Acesso em: 22 nov. 2019. FITZGERALD, Deirdre B. et al. Surgical and non-surgical management of malignant pleural effusions. Expert review of respiratory medicine, v. 12, n. 1, p. 15-26, 2018. Acesso em: 09 set. 2019. HOOPER, Clare et al. Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010. Thorax, v.65, p.4-17, 2010. Acesso em: 09 set. 2019. JEBA, Jenifer et al. Prognostic factors of malignant pleural effusion among palliative care outpatients: A retrospective study. Indian Journal of Palliative Care, v. 24, n. 2, p. 184, 2018. Acesso em: 17 nov, 2020. KOEGELENBERG, Coenraad FN et al. Contemporary best practice in the management of malignant pleural effusion. Therapeutic advances in respiratory disease, v. 12, p. 1753466618785098, 2018. Acesso em: 17 nov, 2020. MARTINS et al. Clínica Médica Volume 3: doenças hematológicas, oncologia, doenças renais. 2. ed. São Paulo: Manole, 2016. p. 1-761. Acesso em: 09 set. 2019. PEREIRA, Carlos Alberto de Castro; HOLANDA, Marcelo Alcantara. Medicina respiratória. 1. ed. São Paulo: Atheneu, 2013. p. 1-2108. Acesso em: 09 set. 2019. PILLING, John E. et al. Prognostic factors for survival after surgical palliation of malignant pleural effusion. Journal of Thoracic Oncology, v. 5, n. 10, p. 1544-1550, 2010. Acesso em: 17 nov, 2020. SKOK, Kristijan et al. Malignant pleural effusion and its current management: a review. Medicina, v. 55, n. 8, p. 490, 2019. Acesso em: 17 nov, 2020. WALKER, Steven; BIBBY, Anna C.; MASKELL, Nick A. Current best practice in the evaluation and management of malignant pleural effusions. Therapeutic advances in respiratory disease, v. 11, n. 2, p. 105-114, 2017. Acesso em: 17 nov, 2020. WORLD HEALTH ORGANIZATION. Noncommunicable diseases country profiles 2018. Disponível em: https://www.who.int/. Acesso em: 20 set. 2019. ZAMBONI, Mauro et al. Fatores prognósticos para a sobrevida dos pacientes com derrame pleural maligno. Pulmão RJ, Rio de Janeiro, v. 25, n. 1, p. 43-52, 2018. Acesso em: 09 set. 2019. |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Centro Universitário de João Pessoa Brasil UNIPÊ |
publisher.none.fl_str_mv |
Centro Universitário de João Pessoa Brasil UNIPÊ |
dc.source.none.fl_str_mv |
reponame:Repositório do Centro Universitário Braz Cubas instname:Centro Universitário Braz Cubas (CUB) instacron:CUB |
instname_str |
Centro Universitário Braz Cubas (CUB) |
instacron_str |
CUB |
institution |
CUB |
reponame_str |
Repositório do Centro Universitário Braz Cubas |
collection |
Repositório do Centro Universitário Braz Cubas |
repository.name.fl_str_mv |
Repositório do Centro Universitário Braz Cubas - Centro Universitário Braz Cubas (CUB) |
repository.mail.fl_str_mv |
bibli@brazcubas.edu.br |
_version_ |
1798311337039757312 |